Activators of peroxisome proliferator-activated receptor-α partially inhibit mouse skin tumor promotion

Philippe Thuillier, Gaby J. Anchiraico, Kwangok P. Nickel, Regina E. Maldve, Irma Gimenez-Conti, Stephanie J. Muga, Kai Li Liu, Susan M. Fischer, Martha A. Belury

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Several recent reports have suggested that peroxisome proliferator-activated receptors (PPARs) may be involved in the development of neoplasias in different tissue types. The present study was undertaken to determine whether PPARs play a role in skin physiology and tumorigenesis. In an initiation-promotion study, SENCAR mice treated topically with the PPARα ligands conjugated linoleic acid and 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid (Wy-14643) exhibited an approximately 30% lower skin tumor yield compared with mice treated with vehicle. The PPARγ and PPARδ activators troglitazone and bezafibrate, respectively, exerted little, if any, inhibitory activity. PPARα was detected in normal and hyperplastic skin and in papillomas and carcinomas by immunohistochemistry. In addition, PPARα, PPARδ/PPARβ, and PPARγ protein levels were analyzed by immunoblotting in normal epidermis and papillomas. Surprisingly, the levels of all three isoforms were increased significantly in tumors as opposed to normal epidermis. In primary keratinocyte cultures, protein levels of PPARα and, to a lesser extent, PPARγ were markedly increased when the cells were induced to differentiate with high-calcium (0.12 mM) conditions. In addition, we observed that Wy-14643 enhanced transcriptional activity of a peroxisome proliferator-response element-driven promoter in a mouse keratinocyte cell line. These results demonstrate that keratinocytes express functional PPARα, that PPARα may play a role in differentiation, and that ligands for PPARα are moderately protective against skin tumor promotion. We conclude that selective PPARα ligands may exert their protective role against skin tumor promotion by ligand activation of PPARα. (C) 2000 Wiley-Liss, Inc.

Original languageEnglish (US)
Pages (from-to)134-142
Number of pages9
JournalMolecular Carcinogenesis
Volume29
Issue number3
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

Peroxisome Proliferator-Activated Receptors
Skin
Neoplasms
Keratinocytes
Ligands
Papilloma
troglitazone
Epidermis
Inbred SENCAR Mouse
Skin Physiological Phenomena
Bezafibrate
Peroxisome Proliferators
Conjugated Linoleic Acids
Response Elements

Keywords

  • 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid
  • Conjugated linoleic acid
  • Epidermis
  • Proliferator-activated receptor
  • Tumor promotion

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology

Cite this

Activators of peroxisome proliferator-activated receptor-α partially inhibit mouse skin tumor promotion. / Thuillier, Philippe; Anchiraico, Gaby J.; Nickel, Kwangok P.; Maldve, Regina E.; Gimenez-Conti, Irma; Muga, Stephanie J.; Liu, Kai Li; Fischer, Susan M.; Belury, Martha A.

In: Molecular Carcinogenesis, Vol. 29, No. 3, 2000, p. 134-142.

Research output: Contribution to journalArticle

Thuillier, P, Anchiraico, GJ, Nickel, KP, Maldve, RE, Gimenez-Conti, I, Muga, SJ, Liu, KL, Fischer, SM & Belury, MA 2000, 'Activators of peroxisome proliferator-activated receptor-α partially inhibit mouse skin tumor promotion', Molecular Carcinogenesis, vol. 29, no. 3, pp. 134-142. https://doi.org/10.1002/1098-2744(200011)29:3<134::AID-MC2>3.0.CO;2-F
Thuillier, Philippe ; Anchiraico, Gaby J. ; Nickel, Kwangok P. ; Maldve, Regina E. ; Gimenez-Conti, Irma ; Muga, Stephanie J. ; Liu, Kai Li ; Fischer, Susan M. ; Belury, Martha A. / Activators of peroxisome proliferator-activated receptor-α partially inhibit mouse skin tumor promotion. In: Molecular Carcinogenesis. 2000 ; Vol. 29, No. 3. pp. 134-142.
@article{09db3b31815f4ce09f83fef2a01df064,
title = "Activators of peroxisome proliferator-activated receptor-α partially inhibit mouse skin tumor promotion",
abstract = "Several recent reports have suggested that peroxisome proliferator-activated receptors (PPARs) may be involved in the development of neoplasias in different tissue types. The present study was undertaken to determine whether PPARs play a role in skin physiology and tumorigenesis. In an initiation-promotion study, SENCAR mice treated topically with the PPARα ligands conjugated linoleic acid and 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid (Wy-14643) exhibited an approximately 30{\%} lower skin tumor yield compared with mice treated with vehicle. The PPARγ and PPARδ activators troglitazone and bezafibrate, respectively, exerted little, if any, inhibitory activity. PPARα was detected in normal and hyperplastic skin and in papillomas and carcinomas by immunohistochemistry. In addition, PPARα, PPARδ/PPARβ, and PPARγ protein levels were analyzed by immunoblotting in normal epidermis and papillomas. Surprisingly, the levels of all three isoforms were increased significantly in tumors as opposed to normal epidermis. In primary keratinocyte cultures, protein levels of PPARα and, to a lesser extent, PPARγ were markedly increased when the cells were induced to differentiate with high-calcium (0.12 mM) conditions. In addition, we observed that Wy-14643 enhanced transcriptional activity of a peroxisome proliferator-response element-driven promoter in a mouse keratinocyte cell line. These results demonstrate that keratinocytes express functional PPARα, that PPARα may play a role in differentiation, and that ligands for PPARα are moderately protective against skin tumor promotion. We conclude that selective PPARα ligands may exert their protective role against skin tumor promotion by ligand activation of PPARα. (C) 2000 Wiley-Liss, Inc.",
keywords = "4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid, Conjugated linoleic acid, Epidermis, Proliferator-activated receptor, Tumor promotion",
author = "Philippe Thuillier and Anchiraico, {Gaby J.} and Nickel, {Kwangok P.} and Maldve, {Regina E.} and Irma Gimenez-Conti and Muga, {Stephanie J.} and Liu, {Kai Li} and Fischer, {Susan M.} and Belury, {Martha A.}",
year = "2000",
doi = "10.1002/1098-2744(200011)29:3<134::AID-MC2>3.0.CO;2-F",
language = "English (US)",
volume = "29",
pages = "134--142",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Activators of peroxisome proliferator-activated receptor-α partially inhibit mouse skin tumor promotion

AU - Thuillier, Philippe

AU - Anchiraico, Gaby J.

AU - Nickel, Kwangok P.

AU - Maldve, Regina E.

AU - Gimenez-Conti, Irma

AU - Muga, Stephanie J.

AU - Liu, Kai Li

AU - Fischer, Susan M.

AU - Belury, Martha A.

PY - 2000

Y1 - 2000

N2 - Several recent reports have suggested that peroxisome proliferator-activated receptors (PPARs) may be involved in the development of neoplasias in different tissue types. The present study was undertaken to determine whether PPARs play a role in skin physiology and tumorigenesis. In an initiation-promotion study, SENCAR mice treated topically with the PPARα ligands conjugated linoleic acid and 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid (Wy-14643) exhibited an approximately 30% lower skin tumor yield compared with mice treated with vehicle. The PPARγ and PPARδ activators troglitazone and bezafibrate, respectively, exerted little, if any, inhibitory activity. PPARα was detected in normal and hyperplastic skin and in papillomas and carcinomas by immunohistochemistry. In addition, PPARα, PPARδ/PPARβ, and PPARγ protein levels were analyzed by immunoblotting in normal epidermis and papillomas. Surprisingly, the levels of all three isoforms were increased significantly in tumors as opposed to normal epidermis. In primary keratinocyte cultures, protein levels of PPARα and, to a lesser extent, PPARγ were markedly increased when the cells were induced to differentiate with high-calcium (0.12 mM) conditions. In addition, we observed that Wy-14643 enhanced transcriptional activity of a peroxisome proliferator-response element-driven promoter in a mouse keratinocyte cell line. These results demonstrate that keratinocytes express functional PPARα, that PPARα may play a role in differentiation, and that ligands for PPARα are moderately protective against skin tumor promotion. We conclude that selective PPARα ligands may exert their protective role against skin tumor promotion by ligand activation of PPARα. (C) 2000 Wiley-Liss, Inc.

AB - Several recent reports have suggested that peroxisome proliferator-activated receptors (PPARs) may be involved in the development of neoplasias in different tissue types. The present study was undertaken to determine whether PPARs play a role in skin physiology and tumorigenesis. In an initiation-promotion study, SENCAR mice treated topically with the PPARα ligands conjugated linoleic acid and 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid (Wy-14643) exhibited an approximately 30% lower skin tumor yield compared with mice treated with vehicle. The PPARγ and PPARδ activators troglitazone and bezafibrate, respectively, exerted little, if any, inhibitory activity. PPARα was detected in normal and hyperplastic skin and in papillomas and carcinomas by immunohistochemistry. In addition, PPARα, PPARδ/PPARβ, and PPARγ protein levels were analyzed by immunoblotting in normal epidermis and papillomas. Surprisingly, the levels of all three isoforms were increased significantly in tumors as opposed to normal epidermis. In primary keratinocyte cultures, protein levels of PPARα and, to a lesser extent, PPARγ were markedly increased when the cells were induced to differentiate with high-calcium (0.12 mM) conditions. In addition, we observed that Wy-14643 enhanced transcriptional activity of a peroxisome proliferator-response element-driven promoter in a mouse keratinocyte cell line. These results demonstrate that keratinocytes express functional PPARα, that PPARα may play a role in differentiation, and that ligands for PPARα are moderately protective against skin tumor promotion. We conclude that selective PPARα ligands may exert their protective role against skin tumor promotion by ligand activation of PPARα. (C) 2000 Wiley-Liss, Inc.

KW - 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid

KW - Conjugated linoleic acid

KW - Epidermis

KW - Proliferator-activated receptor

KW - Tumor promotion

UR - http://www.scopus.com/inward/record.url?scp=0033647407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033647407&partnerID=8YFLogxK

U2 - 10.1002/1098-2744(200011)29:3<134::AID-MC2>3.0.CO;2-F

DO - 10.1002/1098-2744(200011)29:3<134::AID-MC2>3.0.CO;2-F

M3 - Article

C2 - 11108658

AN - SCOPUS:0033647407

VL - 29

SP - 134

EP - 142

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

IS - 3

ER -